Consultation Required

Updated Labs required

Semaglutide is a drug that was originally created for diabetes. It acts on the glucagon like peptide receptor-1 in the hypothalamus and hindbrain portions of the brain to make patients feel full. In so doing, it significantly reduces patients’ appetites causing them to lose significant amounts of weight.

​

​

Tirzepatide, the active ingredient in Mounjaro, is a recently developed weight loss injection that has demonstrated promising results. Tirzepatide acts on multiple hormone receptors, offering a unique approach to reducing appetite, regulating blood sugar levels, and promote weight loss.

​

​